Aug
26
On Tuesday, Varian Medical Systems, Inc. (NYSE:VAR)’s shares declined -2.38% to $77.10.
Varian Medical Systems (VAR), world leader in radiotherapy, has been awarded an eight-year tender to supply advanced radiotherapy equipment and software to a network of hospitals in Galicia, in the northwest of Spain. Varian booked the order, worth an estimated €21m ($23m), in its fiscal third quarter.
Under the terms of the agreement Varian will supply 10 linear accelerators, counting three advanced TrueBeam™ systems, to five hospitals in the SERGAS network of hospitals in the Galicia region. Varian will also be installing its full suite of treatment planning software and oncology information administration systems across the network.
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions in the United States. The company operates in two segments, Oncology Systems and Imaging Components. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, stereotactic radiotherapy, stereotactic body radiotherapy, stereotactic radiosurgery, and brachytherapy. Its products comprise linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, and accessories; and information administration, treatment planning, and image processing software.
Sun Life Financial Inc (NYSE:SLF)’s shares gained 1.49% to $30.03.
Sun Life Financial Inc (SLF) declared that 6,007,314 of its 11,200,000 Class A Non-cumulative Rate Reset Preferred Shares Series 8R (the “Series 8R Shares”) have been elected for conversion on June 30, 2015, on a one-for-one basis, into Class A Non-cumulative Floating Rate Preferred Shares Series 9QR (the “Series 9QR Shares”). Consequently, on June 30, 2015, Sun Life Financial will have 5,192,686 Series 8R Shares and 6,007,314 Series 9QR Shares issued and outstanding. The Series 8R Shares and Series 9QR Shares will be listed on the Toronto Stock Exchange under the symbols SLF.PR.G and SLF.PR.J, respectively.
Subject to regulatory approval, Sun Life Financial may redeem the Series 8R Shares and the Series 9QR Shares in whole or in part on June 30, 2020 and on the 30th of June every five years thereafter.
Sun Life Financial Inc., a financial services organization, provides protection and wealth products and services to individuals and corporate customers worldwide. It operates through Sun Life Financial Canada, Sun Life Financial United States, MFS Investment Administration, and Sun Life Financial Asia segments.
At the end of Tuesday’s trade, DISH Network Corp (NASDAQ:DISH)‘s shares dipped -0.69% to $57.83.
DISH Network L.L.C. and Sinclair Broadcast Group, Inc. have agreed to a short term contract extension as they continue to negotiate a new retransmission agreement. The current agreement was set to expire at 9:59 p.m. MDT last night.
The extension preserves DISH customer access to 153 local channels in 79 markets nationwide.
DISH is asking the Federal Communications Commission to stay action on its Verified Retransmission Complaint and Request for Preliminary Injunctive Relief as the two parties continue to negotiate.
DISH Network Corporation, through its auxiliaries, provides pay TV services in the United States. The company operates through two segments, DISH and Wireless. The company provides video services under the DISH brand. It also offers programming packages that comprise regional and specialty sports channels, premium movie channels, and Latino and international programming through national broadcast netoperates, local broadcast netoperates, and national and regional cable netoperates; and receiver systems. In addition, the company provides satellite broadband services, and wireline voice and broadband services under the dishNET brand; and linear streaming OTT services, which comprise news and children’s programs, in addition to a video on-demand programming library.
AEGON N.V. (ADR) (NYSE:AEG), ended its Tuesday’s trading session with 0.50% gain, and closed at $6.02.
Aegon has accomplished the sale of its Canadian life insurance business to Wilton Re following regulatory approval.
The agreement to sell Aegon’s Canadian life insurance business to Wilton Re for CAD 600 million (EUR 417 million) was declared on October 16, 2014. The transaction will result in a book loss of CAD 1.2 billion (EUR 0.8 billion), which will be booked in the third quarter of 2015. Aegon has earmarked the proceeds of this transaction for the redemption of the USD 500 million 4.625% senior bond, due December 2015.
The combination of the divestment and the non-refinancing of the bond will improve Aegon’s return on equity by about 40 basis points, while reducing net underlying earnings by less than 1%. It will also improve Aegon’s leverage ratio by about 40 basis points on a pro forma basis, while the fixed charge cover ratio will improve by 0.5 times.
Aegon N.V. provides life insurance, pensions, and asset administration services. The company operates through the Americas, the Netherlands, the United Kingdom, and New Markets. The company offers life and protection products, such as traditional and universal life, endowment, term, and whole life insurance products; and supplemental health, accidental death and dismemberment insurance, critical illness, cancer treatment, credit/disability, income protection, travel, and long-term care insurance.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
Comments
Leave a Reply
You must be logged in to post a comment.